Skip to main content
SpringerLink
Log in

Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The dose-dependent and time-dependent effects of the novel antipsychotic compound remoxipride, as well as the reference compounds chlorpromazine, clozapine, haloperidol, pimozide and sulpiride upon the retention of two-way active avoidance (conditioned avoidance responses, CARs) were studied in male rats. The dose-dependent effects of remoxipride as well as haloperidol and chlorpromazine on the acquisition of CARs were also studied. The acquisition and retention of CARs were tested in shuttleboxes using a 1.0-mA shock intensity and a 10-stone signal (1000 Hz). All the compounds studied, including remoxipride, caused a dose-dependent impairment of acquisition and retention of CARs. The effect of remoxipride on CAR acquisition correlated with remoxipride's effectiveness to block the hyperactivity induced by the dopamine (DA) agonist apomorphine. Unlike chlorpromazine and haloperidol, the potency of remoxipride and clozapine for antagonising CAR retention was found at dose levels much lower than those producing cataleptic effects or blocking apomorphine-induced stereotypies. Based on the DA receptor blocking profile and the relative effectiveness to block CAR it is concluded that the mechanism(s) by which clozapine and remoxipride affect CAR differ from typical neuroleptic drugs. This difference may reflect an action upon different subtypes of functionally coupled DA D2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersen PH (1988) Comparison of the pharmacological characteristics of [3H]raclopride and [3]SCH 23390 binding to dopamine receptor in vivo in mouse brain. Eur J Pharmacol 46:113–120

    Google Scholar 

  • Archer T (1983) Signalled and unsignalled avoidance impairments following noradrenaline depletion with DSP4: an hypothesis incorporating an associative and non-associative factor. Scand J Psychol 24:75–87

    Google Scholar 

  • Archer T, Ögren SO, Johansson G, Ross SB (1982) DSP4-Induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion. Psychopharmacology 76:303–309

    Google Scholar 

  • Arnt J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51:321–329

    Google Scholar 

  • Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Goodman LS, Gilman A (eds) The pharmachological basis of therapeutics. MacMillan, New York, pp 387–445

    Google Scholar 

  • Benakis A, Brown JPH, Bernhard P (1984) Autoradiography study of [14C]sulpiride in monkey. Eur J Drug Metab Pharmacokinet 9:365–370

    Google Scholar 

  • Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6:173–196

    Google Scholar 

  • Beninger RJ, Mason ST, Phillips AG, Fibiger HC (1980) The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits. J Pharmacol Exp Ther 213:623–627

    Google Scholar 

  • Billard W, Ruperto W, Crosby G, Iorio LC, Barnett A (1984) Characterization of the binding of3H-SCH 23390, a selective D1 receptor antagonist ligand, in rat striatum. Life Sci 35:1885–1893

    Google Scholar 

  • Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol 2, part I. Classical transmitters in the CNS. Elsevier, Amsterdam, pp 55–122

    Google Scholar 

  • Blackburn JR, Phillips AG (1989) Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic durgs. Psychopharmacology 98:453–459

    Google Scholar 

  • Cook L, Catania AC (1964) Effects of drugs on avoidance and escape behaviour. Fed Proc 23:818–836

    Google Scholar 

  • Cook L, Davidson AB (1978) Behavioral pharmacology: animal models involving aversive control of behavior. In: Lipton A, Dimascio A, Killam K (eds) Psychopharmacology, a generation of progress. Raven Press, New York, pp 563–567

    Google Scholar 

  • Costall B, Naylor RJ (1977) Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen. J Pharm Pharmacol 29:337–342

    Google Scholar 

  • Courvoisier S (1956) Pharmacodynamic basis for the use of chlorpromazine in psychiatry. J Clin Exp Psychopathol Q Rev Psychiatr Neurol 17:25–37

    Google Scholar 

  • Coward DM, Imperato A, Urwyler S, White TG (1989) Biochemical and behavioural properties of clozapine. Psychopharmacology 99:[Suppl] S6-S12

    Google Scholar 

  • Creese I (1987) Biochemical properties of CNS dopamine receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 257–264

    Google Scholar 

  • Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological properties of antischizophrenic drugs. Science 192:481–483

    Google Scholar 

  • Daniel WW (1978) Theil's method. In: Applied nonparametric statistics. Houghton Miffin, Boston, pp 351–358

    Google Scholar 

  • Ellenbroek B, Schwarz M, Sontag K-H, Jaspers R, Cools A (1985) Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats. Brain Res 345:132–140

    Google Scholar 

  • Fibiger HC, Phillips AG, Zis AP (1974) Deficits in instrumental responding after 6-hydrodopamine lesions of the nigro-neostriatal dopaminergic projection. Pharmacol Biochem Behav 2:87–96

    Google Scholar 

  • Fibiger HC, Zis AP, Phillips AG (1975) Haloperidol-induced disruption of conditioned avoidance responding: attenuation by prior training or by anticholinergic drugs. Eur J Pharmacol 30:309–314

    Google Scholar 

  • Fog R, Randrup A, Pakkenberg H (1970) Lesions in corpus striatum and corex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour. Psychopharmacologia 18:346–356

    Google Scholar 

  • Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244–254

    Google Scholar 

  • Hall H, Sällemark M, Jerning E (1986) Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. Acta Pharmacol Toxicol 58:61–70

    Google Scholar 

  • Hanson HM, Stone CA, Witoslawski JJ (1970) Antagonism of the antiavoidance effects of various agents by anticholinergic drugs. J Pharmacol Exp Ther 173:117–124

    Google Scholar 

  • Hyttel J (1978) Effects of neuroleptics on3H-haloperidol and3H-cis(Z)-flupenthixol binding and adenylate cyclase activity in vitro. Life Sci 23:551–556

    Google Scholar 

  • Hyttel J (1980) Further evidence that3H-cis(Z)-flupenthixol binds to the adenylate cyclate-associated receptor (D1) in the rat corpus striatum. Psychopharmacology 67:107–109

    Google Scholar 

  • Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopamine systems. J. Pharmacol Exp Ther 226:462–468

    Google Scholar 

  • Iorio LC, Cohen M, Coffin VL (1991) Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats. J Pharmacol Exp Ther 258[1]:118–123

    Google Scholar 

  • Iversen SD (1983) Behavioral effects of manipulation of basal ganglia neurotransmitters. In: Functions of the basal ganglia, Ciba Foundation Symposium 107. Pitman, London, pp 183–200

    Google Scholar 

  • Jansen PAJ, Niemegeers CJS, Schellekens KHL (1966) Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part III. The subcutaneous and oral activity in rats and dogs of 56 neuroleptic drugs in the jumping box test. Arzneimittelforschung 16:339–346

    Google Scholar 

  • Koffer KB, Berney S, Hornykiewicz O (1978) The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy. Eur J Pharmacol 47:81–86

    Google Scholar 

  • Köhler C, Hall H, Magnusson O, Lewander T, Gustafsson K (1990) Biochemical pharmacology of the atypical neuroleptic remoxipride. Acta Psychiatr Scand 82:27–36

    Google Scholar 

  • Köhler C, Radesäter AC, Karlsson-Boethius G, Bryske B, Widman M (1992) Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain. J Neural Transm 87:49–62

    Google Scholar 

  • Koob GF, Hervé S, Herman JP, Le Moal M (1984) Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems. Brain Res 303:319–329

    Google Scholar 

  • Ljungberg T, Apicella P, Schultz W (1991) Responses of monkey midbrain dopamine neurons during delayed alternation performance. Brain Res 567:337–341

    Google Scholar 

  • Malmberg Å, Jackson DM, Eriksson A, Mohell NA (1993) Unique binding characteristics of neuroleptic agents interacting with human dopamine D2A, D2B and D3 receptors. Mol Pharmacol 43:749–754

    Google Scholar 

  • Niemegeers CJE, Janssen PAJ (1979) A systematic study of the pharmacological activities of dopamine antagonists. Life Sci 24:2201–2216

    Google Scholar 

  • Nishibe Y, Matsuo Y, Yoshizaki T, Eigyo M, Shiomi T, Hirose K (1982) Differential effects of sulpiride and metoclopramide on brain homovanillic acid levels and shuttle box avoidance after systemic and intracerebral administration. Naunyn Schmiedebergs Arch Pharmacol 321:190–194

    Google Scholar 

  • Ögren SO, Fuxe K (1974) Learning, brain noradrenaline and the pituitary — adrenal axis. Med Biol 52:399–405

    Google Scholar 

  • Ögren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Ängeby K, Florvall L (1984) Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur J Pharmacol 102:459–474

    Google Scholar 

  • Ögren SO, Hall H, Köhler C, Magnusson O, Sjöstrand SE (1986) The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine mediated motor functions. Psychopharmacology 90:287–294

    Google Scholar 

  • Ögren SO, Florvall L, Hall H, Magnusson O, Ängeby-Möller K (1990) Neuropharmacolgical and behavioural properties of remoxipride in the rat. Acta Psychiatr Scand [Suppl 358] 82:21–26

    Google Scholar 

  • Ögren SO, Thyréen G, Lindeberg A, Amkéus E (1994) Remoxipride differs from other dopamine receptor antagonists in two tests of catalepsy in the rat. Differential effects on dopamine receptor functions in the striatum. Psychopharmacology, submitted

  • Posluns D (1962) An analysis of chlorpromazine-induced suppression of the avoidance response. Psychopharmacologia 3:361–373

    Google Scholar 

  • Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133–152

    Google Scholar 

  • Sen PK (1968) Estimates of the regression coefficient based on Kendall's Tau. J Am Statist Assoc 63:1379–1389

    Google Scholar 

  • Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146–151

    Google Scholar 

  • Trabucchi M, Longoni R, Fresia P, Spano PF (1975) Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain. Life Sci 17:1551–1556

    Google Scholar 

  • Van den Bos R, Cools AR (1989) The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviours. Life Sci 44:1697–1704

    Google Scholar 

  • Van Tol HHM, Bunzow JR, Guan H-C, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610–614

    Google Scholar 

  • Wadenberg M-L, Ericson EL, Magnusson O, Ahlenius S (1990) Supression of conditioned avoidance behavior by the local application of (-) sulpiride into the ventral, but not the dorsal, striatum of the rat. Biol Psychiatry 28:297–307

    Google Scholar 

  • Weiner I (1990) Neural substrates of latent inhibition: the switching model. Psychol Bull 108:442–461

    Google Scholar 

  • Wise RA, Spindler J, DeWit H, Gerser GJ (1978) Neuroleptic-induced “anhedonia” in rats. Pimozide blocks reward quality of food. Science 201:262–264

    Google Scholar 

  • Zis AP, Fibiger HC, Phillips AB (1974) Reversal by L-DOPA of impaired learning due to destruction of the dopaminergic nigro-neostriatal projection. Science 185:960–962

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Astra Arcus AB, CNS Preclinical R&D, S-151 85, Södertälje, Sweden

    Sven Ove Ögren

  2. Department of Psychology, Gothenburg University, Box 141 58, S-400 20, Gothenburg, Sweden

    Trevor Archer

Authors
  1. Sven Ove Ögren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Trevor Archer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ögren, S.O., Archer, T. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile. Psychopharmacology 114, 383–391 (1994). https://doi.org/10.1007/BF02249327

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02249327

Key words

Search

Navigation